Gao, Chundi et al. published their research in Future Oncology in 2022 |CAS: 443-72-1

The Article related to expression pattern clin relevance regulator cancer type, n6-methyladenine, correlation, pan-cancer, regulatory factor, survival, Placeholder for records without volume info and other aspects.Quality Control of N-Methyl-7H-purin-6-amine

Gao, Chundi; Yu, Haiyang; Li, Huayao; Liu, Cun; Ma, Xiaoran; Zhuang, Jing; Sun, Changgang published an article in 2022, the title of the article was Analysis of the expression patterns and clinical relevance of m6A regulators in 33 cancer types.Quality Control of N-Methyl-7H-purin-6-amine And the article contains the following content:

The role of N6-methyladenine (m6A) RNA methylation in a variety of biol. processes is gradually being revealed. Here, we systematically describe the correlation between the expression pattern of m6A RNA methylation regulatory factors and clin. phenotype, immunity, drug sensitivity, stem cells and prognosis in more than 10,000 samples of 33 types of cancer. The results show that there are significant differences in the expression of 20 m6A RNA methylation regulatory factors in different cancers, and there was a significant correlation with the anal. indicators. In this study, the m6A RNA methylation regulatory factor was found not only to potentially assist in stratifying the prognosis but also to predict or improve the sensitivity of clin. drug therapy. The experimental process involved the reaction of N-Methyl-7H-purin-6-amine(cas: 443-72-1).Quality Control of N-Methyl-7H-purin-6-amine

The Article related to expression pattern clin relevance regulator cancer type, n6-methyladenine, correlation, pan-cancer, regulatory factor, survival, Placeholder for records without volume info and other aspects.Quality Control of N-Methyl-7H-purin-6-amine

Referemce:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem